Literature DB >> 28195318

Biallelic loss-of-function variants in DOCK3 cause muscle hypotonia, ataxia, and intellectual disability.

K L Helbig1, C Mroske1, D Moorthy2, S A Sajan1, M Velinov2,3.   

Abstract

DOCK3 encodes the dedicator of cytokinesis 3 protein, a member of the DOCK180 family of proteins that are characterized by guanine-nucleotide exchange factor activity. DOCK3 is expressed exclusively in the central nervous system and plays an important role in axonal outgrowth and cytoskeleton reorganization. Dock3 knockout mice exhibit motor deficiencies with abnormal ataxic gait and impaired learning. We report 2 siblings with biallelic loss-of-function variants in DOCK3. Diagnostic whole-exome sequencing (WES) and chromosomal microarray were performed on a proband with severe developmental disability, hypotonia, and ataxic gait. Testing was also performed on the proband's similarly affected brother. A paternally inherited 458 kb deletion in chromosomal region 3p21.2 disrupting the DOCK3 gene was identified in both affected siblings. WES identified a nonsense variant c.382C>G (p.Gln128*) in the DOCK3 gene (NM_004947) on the maternal allele in both siblings. Common features in both affected individuals include severe developmental disability, ataxic gait, and severe hypotonia, which recapitulates the Dock3 knockout mouse phenotype. We show that complete DOCK3 deficiency in humans leads to developmental disability with significant hypotonia and gait ataxia, probably due to abnormal axonal development.
© 2017 The Authors. Clinical Genetics published by John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  DOCK3; ataxia; developmental disability; whole-exome sequencing

Mesh:

Substances:

Year:  2017        PMID: 28195318     DOI: 10.1111/cge.12995

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  11 in total

1.  Variants in DOCK3 cause developmental delay and hypotonia.

Authors:  Kimberly Wiltrout; Alejandro Ferrer; Ingrid van de Laar; Kazuhiko Namekata; Takayuki Harada; Eric W Klee; Michael T Zimmerman; Margot A Cousin; Jennifer L Kempainen; Dusica Babovic-Vuksanovic; Marjon A van Slegtenhorst; Coranne D Aarts-Tesselaar; Rhonda E Schnur; Marisa Andrews; Marwan Shinawi
Journal:  Eur J Hum Genet       Date:  2019-04-11       Impact factor: 4.246

2.  DOCK3-related neurodevelopmental syndrome: Biallelic intragenic deletion of DOCK3 in a boy with developmental delay and hypotonia.

Authors:  Aiko Iwata-Otsubo; Alyssa L Ritter; Brooke Weckselbatt; Nicole R Ryan; David Burgess; Laura K Conlin; Kosuke Izumi
Journal:  Am J Med Genet A       Date:  2017-11-12       Impact factor: 2.802

Review 3.  Key role of Rho GTPases in motor disorders associated with neurodevelopmental pathologies.

Authors:  David I Anderson; Evelyne Bloch-Gallego
Journal:  Mol Psychiatry       Date:  2022-08-02       Impact factor: 13.437

Review 4.  DOCKopathies: A systematic review of the clinical pathologies associated with human DOCK pathogenic variants.

Authors:  Adrienne Samani; Katherine G English; Michael A Lopez; Camille L Birch; Donna M Brown; Gurpreet Kaur; Elizabeth A Worthey; Matthew S Alexander
Journal:  Hum Mutat       Date:  2022-05-20       Impact factor: 4.700

5.  DOCK3 is a dosage-sensitive regulator of skeletal muscle and Duchenne muscular dystrophy-associated pathologies.

Authors:  Andrea L Reid; Yimin Wang; Adrienne Samani; Rylie M Hightower; Michael A Lopez; Shawn R Gilbert; Lara Ianov; David K Crossman; Louis J Dell'Italia; Douglas P Millay; Thomas van Groen; Ganesh V Halade; Matthew S Alexander
Journal:  Hum Mol Genet       Date:  2020-10-10       Impact factor: 6.150

6.  A Genocentric Approach to Discovery of Mendelian Disorders.

Authors:  Adam W Hansen; Mullai Murugan; He Li; Michael M Khayat; Liwen Wang; Jill Rosenfeld; B Kim Andrews; Shalini N Jhangiani; Zeynep H Coban Akdemir; Fritz J Sedlazeck; Allison E Ashley-Koch; Pengfei Liu; Donna M Muzny; Erica E Davis; Nicholas Katsanis; Aniko Sabo; Jennifer E Posey; Yaping Yang; Michael F Wangler; Christine M Eng; V Reid Sutton; James R Lupski; Eric Boerwinkle; Richard A Gibbs
Journal:  Am J Hum Genet       Date:  2019-10-24       Impact factor: 11.025

Review 7.  The DOCK protein family in vascular development and disease.

Authors:  Clare E Benson; Laura Southgate
Journal:  Angiogenesis       Date:  2021-02-06       Impact factor: 10.658

Review 8.  NGS Technologies as a Turning Point in Rare Disease Research , Diagnosis and Treatment.

Authors:  Ana Fernandez-Marmiesse; Sofia Gouveia; Maria L Couce
Journal:  Curr Med Chem       Date:  2018-01-30       Impact factor: 4.530

Review 9.  Genomic Copy Number Variations in the Autism Clinic-Work in Progress.

Authors:  Milen Velinov
Journal:  Front Cell Neurosci       Date:  2019-02-19       Impact factor: 5.505

10.  Genome survey, high-resolution genetic linkage map construction, growth-related quantitative trait locus (QTL) identification and gene location in Scylla paramamosain.

Authors:  Ming Zhao; Wei Wang; Wei Chen; Chunyan Ma; Fengying Zhang; Keji Jiang; Junguo Liu; Le Diao; Heng Qian; Junxia Zhao; Tian Wang; Lingbo Ma
Journal:  Sci Rep       Date:  2019-02-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.